Bio-Rad CFX Opus 96 Real-Time PCR System
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), has issued a Presolicitation / Notice of Intent to award a Firm-Fixed-Price Purchase Order for one Bio-Rad CFX Opus 96 Real-Time PCR System. This system is required by the Laboratory of Receptor Biology and Gene Expression Branch (LRBGE) for Dr. Thomas Misteli's lab in Bethesda, MD. While this is not a request for competitive quotes, small businesses are invited to submit capability statements by June 10, 2026, to potentially compete the award.
Purpose & Overview
This notice serves as the NIH's intent to procure a new, commercially available Bio-Rad CFX Opus 96 Real-Time PCR System directly from Bio-Rad Laboratories, Inc. The system is essential for chromatin and cancer research workflows within the LRBGE at NCI, located in Bethesda, MD.
Key Requirements / Deliverables
- One (1) new, commercially available Bio-Rad CFX Opus 96 Real-Time PCR System.
- Must be a 96-well, 5-color plus FRET, network-connected real-time PCR detection platform.
- Support gene expression analysis, assay optimization, plate setup, data collection, statistical analysis, and graphing of results.
- Provide sensitivity, thermal performance, temperature gradient capability, compact design, and optical precision.
Submission & Evaluation
This is explicitly not a request for competitive quotes. However, the Government is seeking capability statements from interested small businesses (including 8(a), service-disabled veteran owned, HUBZone, small disadvantaged, veteran-owned, and women-owned). These statements will be evaluated to determine if the proposed award should be competed. Failure to submit a capability statement may result in the award proceeding as intended to Bio-Rad Laboratories, Inc.
Contract Details
- Type: Firm-Fixed-Price Purchase Order.
- Anticipated Award: Approximately ten (10) days after the notice date, unless a capable alternative vendor is identified.
Eligibility / Set-Aside
This opportunity is specifically seeking capability statements from small businesses across various categories to assess potential competition.
Notes
Interested parties must email their responses to david.shen@nih.gov no later than 11:00 p.m. EDT on June 10, 2026.